Verano Holdings (VRNO) Total Debt (2021 - 2026)
Verano Holdings' (VRNO) quarterly Total Debt came in at $395.1 million in Q1 2026, down 2.31% year-on-year from $404.4 million in Q1 2025, and up 0.75% on a QoQ basis from $392.2 million in Q4 2025.
Verano Holdings (VRNO) Total Debt (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Total Debt data on file, last reported at $395.1 million in Q1 2026.
- On a quarterly basis, Total Debt fell 2.31% year-over-year to $395.1 million in Q1 2026; TTM through Mar 2026 was $395.1 million, a 2.31% decrease from a year earlier, with the FY2025 full-year figure at $392.2 million, down 9.22% from the prior year.
- Total Debt for Q1 2026 stood at $395.1 million, up from $392.2 million in the prior quarter.
- Over the last five years, Total Debt for VRNO reached as high as $445.9 million in Q3 2022 and fell as low as -$4.8 million in Q1 2022.
- Historically, Total Debt has averaged $392.0 million across 5 years, with a median of $404.4 million in 2025.
- Across the five-year window, Total Debt decreased 17.11% in 2022 and surged 9136.24% in 2023, its largest moves.
- Year by year, Total Debt stood at $413.0 million in 2022, then fell by 3.74% to $397.6 million in 2023, then increased by 8.67% to $432.0 million in 2024, then fell by 9.22% to $392.2 million in 2025, then gained by 0.75% to $395.1 million in 2026.
- Per Business Quant data, the three most recent Total Debt figures were $395.1 million in Q1 2026, $392.2 million in Q4 2025, and $400.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 395.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 395.10 Mn |
| Dec 31, 2025 | 392.15 Mn |
| Sep 30, 2025 | 400.76 Mn |
| Jun 30, 2025 | 403.76 Mn |
| Mar 31, 2025 | 404.44 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 442.68 Mn |
| Jun 30, 2024 | 399.83 Mn |
| Mar 31, 2024 | 444.69 Mn |
| Dec 31, 2023 | 397.55 Mn |
| Sep 30, 2023 | 422.18 Mn |
| Jun 30, 2023 | 441.80 Mn |
| Mar 31, 2023 | 430.13 Mn |
| Dec 31, 2022 | 413.00 Mn |
| Sep 30, 2022 | 445.87 Mn |
| Jun 30, 2022 | 402.63 Mn |
| Mar 31, 2022 | -4.76 Mn |
| Dec 31, 2021 | 498.27 Mn |